1. Home
  2. AIBZ vs OABI Comparison

AIBZ vs OABI Comparison

Compare AIBZ & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bitzero Holdings Inc. Common Shares

AIBZ

Bitzero Holdings Inc. Common Shares

N/A

Current Price

$4.17

Market Cap

358.4M

Sector

N/A

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.10

Market Cap

294.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIBZ
OABI
Founded
N/A
2012
Country
Canada
United States
Employees
8
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.4M
294.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AIBZ
OABI
Price
$4.17
$4.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
363.2K
2.1M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.56
EPS
N/A
N/A
Revenue
N/A
$18,666,000.00
Revenue This Year
N/A
$52.42
Revenue Next Year
N/A
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.44
$1.32
52 Week High
$9.91
$5.43

Technical Indicators

Market Signals
Indicator
AIBZ
OABI
Relative Strength Index (RSI) 32.57 51.56
Support Level N/A $1.71
Resistance Level $7.21 $5.43
Average True Range (ATR) 0.39 0.33
MACD -0.09 -0.13
Stochastic Oscillator 8.87 4.28

Price Performance

Historical Comparison
AIBZ
OABI

About AIBZ Bitzero Holdings Inc. Common Shares

Bitzero Holdings Inc is a provider of IT energy infrastructure and high-efficiency power for data centers. It focuses on data center development, Bitcoin mining, and obtaining strategic data center hosting partnerships. The company has four data center locations in the North American and Scandinavian regions, powered by clean, low-carbon energy sources. The company is driven by experience in infrastructure and a passion for positive change to become the international leader in Blockchain mining and HPC hosting in a sustainable fashion that emphasizes the long-term value proposition for all stakeholders.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: